aTyr Pharma Grants 12,200 Stock Options Under Nasdaq Listing Rule
ByAinvest
Friday, Feb 20, 2026 4:02 pm ET1min read
ATYR--
aTyr Pharma has granted nonstatutory stock options to two employees for 12,200 shares of common stock at an exercise price of $0.98 per share, in accordance with Nasdaq Listing Rule 5635(c)(4). The options vest over four years, with 25% vesting after one year and the remaining 75% vesting over three years. This was granted as an inducement for the new employees joining the company.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet